Применение Трипторелина в послеоперационном периоде у женщин c эктопической беременностью и генитальным эндометриозом

OA: green CC0
🔓 Open OA copy Full text JSON View on OpenAlex
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

Triptorelin (3.75 mg Decapeptyl) given for six months postoperatively improved clinical and morphological outcomes, normalized tumor markers, and aided pregnancy in women with ectopic pregnancy and endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-10 · read from full text ⓘ

The provided text does not contain the content of a research paper, but rather an error message from a website security system called Anubis. This system employs a Proof-of-Work scheme to protect against automated scraping by AI companies, requiring users to complete a computational challenge before accessing the site. The message explains that this is a temporary measure while more advanced fingerprinting techniques are developed to distinguish between legitimate users and headless browsers. Consequently, no scientific data, methods, or findings regarding medical treatments or conditions can be extracted from this input. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Проведена комплексна оцінка використання Триптореліну (Дифереліну 3,75) у післяопераційному періоді у жінок з ектопічною вагітністю та геніальним ендометріозом. Особливості метаболічного впливу триптореліну разом з високою ефективністю дозволяють вважати його препаратом вибору для терапії генітального ендометріозу у жінок з ектопічною вагітністю. Найкращі результати лікування препарат Трипторелін дає при використанні протягом 6 місяців (1 ін’єкція у 28 днів). Критерієм його ефективності слугує клініко-морфологічна картина захворювання, покращення показників онкомаркерів сиворотки крові та ретроспективний аналіз наставання вагітності у перший рік після закінчення лікування.
Full text 1,068 characters · extracted from oa-html · click to expand
Making sure you're not a bot! Loading... You are seeing this because the administrator of this website has set up Anubis to protect the server against the scourge of AI companies aggressively scraping websites. This can and does cause downtime for the websites, which makes their resources inaccessible for everyone. Anubis is a compromise. Anubis uses a Proof-of-Work scheme in the vein of Hashcash, a proposed proof-of-work scheme for reducing email spam. The idea is that at individual scales the additional load is ignorable, but at mass scraper levels it adds up and makes scraping much more expensive. Ultimately, this is a placeholder solution so that more time can be spent on fingerprinting and identifying headless browsers (EG: via how they do font rendering) so that the challenge proof of work page doesn't need to be presented to users that are much more likely to be legitimate. Please note that Anubis requires the use of modern JavaScript features that plugins like JShelter will disable. Please disable JShelter or other such plugins for this domain.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK